Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin&rsquo;s lymphoma

doi:10.3748/wjg.v20.i17.5165

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 17

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6230)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

418

WORD

217

HTML

3164

Figures (1-2)

222

Tables (1-1)

166

Sum=4187

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

969

Download

1074

Sum=2043

May 7, 2014 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. May 7, 2014; 20(17): 5165-5170
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.5165

Open in New Tab Full Size Figure Download Figure

Figure 1 Time course of serum hepatitis B virus DNA and alanine aminotransferase levels during and after immunochemotherapy. HBsAg: Hepatitis B surface antigen; ALT: Alanine aminotransferase.

Open in New Tab Full Size Figure Download Figure

Figure 2 Time course of quantitative titers of hepatitis B surface antigen and hepatitis B surface antibody antibodies after entecavir treatment. Anti-HBs: Hepatitis B surface antibody; HBsAg: Hepatitis B surface antigen.

Citation: Liu WP, Zheng W, Song YQ, Ping LY, Wang GQ, Zhu J. Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin’s lymphoma. World J Gastroenterol 2014; 20(17): 5165-5170
URL: https://www.wjgnet.com/1007-9327/full/v20/i17/5165.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i17.5165